AbCellera Biologics Inc.ABCLNASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P14
Within normal range
vs 5Y Ago
-21.7x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-174.07M | +6.9% |
| 2024 | $-186.95M | -54.0% |
| 2023 | $-121.38M | -159.3% |
| 2022 | $204.70M | +10.0% |
| 2021 | $186.13M | +2221.7% |
| 2020 | $8.02M | +715.3% |
| 2019 | $-1.30M | +25.2% |
| 2018 | $-1.74M | - |